A cross-sectional analysis of late-life cardiovascular factors and their relation to clinically defined neurodegenerative diseases

Alzheimer Disease and Associated Disorders

Volumn 30, Issue 3, 2016, Pages 223-229

  Dugger, Brittany N ^a   Malek Ahmadi, Michael ^a   Monsell, Sarah E ^b   Kukull, Walter A ^b   Woodruff, Bryan K ^c   Reiman, Eric M ^d   Beach, Thomas G ^a   Wilson, Jeffrey ^e  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c BANNER ALZHEIMER S INSTITUTE   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer disease; Body mass index; Corticobasal degeneration; Dementia with Lewy bodies; Parkinson disease; Progressive supranuclear palsy

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR PARAMETERS; COMORBIDITY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; CROSS-SECTIONAL STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIINFARCT DEMENTIA; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; COMPLICATION; FACTUAL DATABASE; NEUROPSYCHOLOGICAL TEST; RISK FACTOR;

AGED; ATRIAL FIBRILLATION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84954349438     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000138     Document Type: Article

References (40)

1. Hayden KM, Zandi PP, Lyketsos CG, et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord. 2006;20:93-100.
2. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672-2713.
3. Stewart R, Masaki K, Xue QL, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2005;62:55-60.
4. White L, Launer L. Relevance of cardiovascular risk factors and ischemic cerebrovascular disease to the pathogenesis of Alzheimer disease: a review of accrued findings from the Honolulu-Asia Aging Study. Alzheimer Dis Assoc Disord. 2006;20:S79-S83.
5. Buchman AS, Wilson RS, Bienias JL, et al. Change in body mass index and risk of incident Alzheimer disease. Neurology. 2005;65:892-897.
6. Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology. 2005;64:494-500.
7. Toledo JB, Arnold SE, Raible K, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain. 2013;136:2697-2706.
8. Peltz CB, Corrada MM, Berlau DJ, et al. Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors. Alzheimers Dement. 2012;8:87-94.
9. Emmerzaal TL, Kiliaan AJ, Gustafson DR. 2003-2013: a decade of body mass index, Alzheimer's disease, and dementia. J Alzheimers Dis. 2015;43:739-755.
10. Gu Y, Scarmeas N, Cosentino S, et al. Change in body mass index before and after Alzheimer's disease onset. Curr Alzheimer Res. 2014;11:349-356.
11. Buchman AS, Schneider JA, Wilson RS, et al. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology. 2006;67:1949-1954.
12. Beach TG, Maarouf CL, Brooks RG, et al. Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease. BMC Geriatr. 2011;11:3.
13. Singh S, Mulley GP, Losowsky MS. Why are Alzheimer patients thin? Age Ageing. 1988;17:21-28.
14. Sanderson M, Wang J, Davis DR, et al. Co-morbidity associated with dementia. Am J Alzheimers Dis Other Demen. 2002;17:73-78.
15. Wolf-Klein GP, Siverstone FA, Brod MS, et al. Are Alzheimer patients healthier? J Am Geriatr Soc. 1988;36:219-224.
16. Kokjohn TA, Maarouf CL, Roher AE. Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray? Alzheimers Dement. 2012;8:574-583.
17. Zaccai J, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005;34:561-566.
18. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol. 2005;4:771-780.
19. Beekly DL, Ramos EM, Lee WW, et al. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord. 2007;21:249-258.
20. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006;20:210-216.
21. Dobson AJ. An Introduction to Generalized Linear Models, Second Edition. Boca Raton, FL: CRC Press; 2001.
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B (Methodological). 1995;57:289-300.
23. Tolppanen AM, Ngandu T, Kareholt I, et al. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis. 2014;38:201-209.
24. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and latelife obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66:336-342.
25. Dugger BN, Adler CH, Shill HA, et al. Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord. 2014;20:525-529.
26. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol. 1991;82:239-259.
27. Schultz C, Ghebremedhin E, Braak H, et al. Neurofibrillary pathology in the human paraventricular and supraoptic nuclei. Acta Neuropathol. 1997;94:99-102.
28. Valdearcos M, Xu AW, Koliwad SK. Hypothalamic inflammation in the control of metabolic function. Annu Rev Physiol. 2015;77:131-160.
29. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging. 2005;32:486-510.
30. Markus HS, Tomkins AM, Stern GM. Increased prevalence of undernutrition in Parkinson's disease and its relationship to clinical disease parameters. J Neural Transm Park Dis Dement Sect. 1993;5:117-125.
31. Abbott RA, Cox M, Markus H, et al. Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr. 1992;46:879-884.
32. Jaafar AF, Gray WK, Porter B, et al. A cross-sectional study of the nutritional status of community-dwelling people with idiopathic Parkinson's disease. BMC Neurol. 2010;10:124.
33. Adler CH. Premotor symptoms and early diagnosis of Parkinson's disease. Int J Neurosci. 2011;121(suppl 2):3-8.
34. McKinnon J, Evidente V, Driver-Dunckley E, et al. Olfaction in the elderly: a cross-sectional analysis comparing Parkinson's disease with controls and other disorders. Int J Neurosci. 2010;120:36-39.
35. Serby M, Larson P, Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry. 1991;148:357-360.
36. Mesholam RI, Moberg PJ, Mahr RN, et al. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol. 1998;55:84-90.
37. Grammas P. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation. 2011;8:26.
38. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813-817.
39. Corder EH, Ervin JF, Lockhart E, et al. Cardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC. J Biomed Biotechnol. 2005;2005:189-197.
40. Helzner EP, Luchsinger JA, Scarmeas N, et al. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol. 2009;66:343-348.